SCHEMBL12015487

SCHEMBL12015487

CC(F)(F)C(=O)OC1CCCCC1N1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ SLC18A3 Q16572 3/20 0.44
▸ OPRM1 P35372 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CHRM3 P20309 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ SIGMAR1 Q99720 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12015482 0.98 SLC18A3 (0.43) SLC18A3OPRM1OPRK1MEN1ALDH1A1
SCHEMBL12015481 0.88 SLC18A3 (0.40) SLC18A3OPRM1OPRK1ALDH1A1
SCHEMBL13174350 0.88 SLC18A3 (0.40) SLC18A3OPRM1OPRK1ALDH1A1CHRM3
SCHEMBL12017269 0.81 SLC18A3 (0.39) SLC18A3OPRM1OPRK1MEN1ALDH1A1
SCHEMBL12017270 0.80 SLC18A3 (0.38) SLC18A3OPRM1OPRK1MEN1ALDH1A1
SCHEMBL28014789 0.77 SLC18A3 (0.46) SLC18A3OPRM1OPRK1MEN1ALDH1A1
SCHEMBL685770 0.75 NPY1R (0.39) ALDH1A1
SCHEMBL28014791 0.74 SLC18A3 (0.43) SLC18A3OPRM1OPRK1MEN1ALDH1A1
SCHEMBL685771 0.71 NPY1R (0.36) ALDH1A1
SCHEMBL12015488 0.71 TDP1 (0.36) SLC18A3OPRM1OPRK1MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9176378-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-03 — — US disclosed
US-8921028-B2 Salt, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-30 — — US disclosed
US-8735047-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-27 — — US disclosed
US-8574812-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-11-05 — — US disclosed
US-8460851-B2 Salt and photoresist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-06-11 — — US disclosed
US-20130022919-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-24 — — US disclosed
US-20120258404-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-11 — — US disclosed
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-13 — — US disclosed
US-20120219906-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 — — US disclosed
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, RCOR3, REN SLC18A3 3552/4885OPRM1 3897/4885OPRK1 3615/4885
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME CLIC1, SLC10A6, APOL1 SLC18A3 2876/4885OPRM1 265/4885OPRK1 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback